Shares of Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of GBX 56.30 and traded as high as GBX 58. Beximco Pharmaceuticals shares last traded at GBX 58, with a volume of 71,858 shares changing hands.
Beximco Pharmaceuticals Price Performance
The company has a market capitalization of £258.75 million, a price-to-earnings ratio of 0.03 and a beta of 0.25. The company has a debt-to-equity ratio of 5.27, a quick ratio of 0.37 and a current ratio of 4.13. The business has a 50-day simple moving average of GBX 56.30 and a two-hundred day simple moving average of GBX 47.82.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Read More
- Five stocks we like better than Beximco Pharmaceuticals
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
